Position in IMRX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,928,190
-$428,964 QoQ
Shares Held
386,411
-13.6% QoQ
Ownership
0.597%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#17
of 111 holders
Holding Since
Sep 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IMRX Over Time
Shares Held
Position Value (USD)
Derivatives in IMRX
reported options exposure · as of Jun 30, 2026CallValue
$366,266
CallShares
73,400
PutValue
$307,384
PutShares
61,600
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026CITADEL ADVISORS LLC holds $6,088,670,182 across 436 Biotechnology names. IMRX ranks #206 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
|
1,425,517 | $406,229,578 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
3,760,028 | $280,046,885 | |
| 3 | INSM |
INSMED Inc
|
2,556,973 | $272,624,460 | |
| 4 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
507,233 | $272,358,759 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
510,430 | $253,545,893 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,006,676 | $242,578,715 | |
| 7 | MANE |
Veradermics, Inc
|
1,877,775 | $230,853,658 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
5,576,261 | $197,343,876 |
All Filings in IMRX
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $366,266 | 73,400 | Call | Defined | 2026-08-14 | |
| 2026-06-30 | $307,384 | 61,600 | Put | Defined | 2026-08-14 | |
| 2026-06-30 | $1,928,190 | 386,411 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,357,154 | 447,278 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $328,321 | 62,300 | Put | Defined | 2026-05-15 | |
| 2026-03-31 | $102,765 | 19,500 | Call | Defined | 2026-05-15 | |
| 2025-12-31 | $595,219 | 90,459 | Shares | Defined | 2026-02-17 | |
| 2025-12-31 | $109,228 | 16,600 | Put | Defined | 2026-02-17 | |
| 2025-12-31 | $340,186 | 51,700 | Call | Defined | 2026-02-17 | |
| 2025-09-30 | $6,602,008 | 943,144 | Shares | Defined | 2025-11-14 | |
| 2024-06-30 | $2,409,134 | 1,882,136 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,439,557 | 1,882,200 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $15,273,975 | 2,078,092 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $15,869,728 | 2,066,371 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $21,005,699 | 2,071,568 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $20,436,180 | 2,104,653 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $10,386,260 | 2,141,497 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $31,287,896 | 2,184,909 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,897,720 | 2,199,209 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $13,971,524 | 2,159,432 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $33,279,508 | 2,058,102 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $54,572,436 | 2,055,459 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||